Dupilumab and tezepelumab in severe refractory asthma: new opportunities
Bronchial asthma is a chronic inflammatory condition with increasing prevalence worldwide that may present as heterogeneous phenotypes defined by the T2-mediated pattern of airway inflammation T2-high and T2-low asthma. Severe refractory asthma includes a subset of asthmatic patients who fail to con...
Saved in:
Main Authors: | Beatrice Ragnoli (Author), Jaymin Morjaria (Author), Patrizia Pignatti (Author), Paolo Montuschi (Author), Mariangela Barbieri (Author), Lucrezia Mondini (Author), Luca Ruggero (Author), Liliana Trotta (Author), Mario Malerba (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
by: Mario Malerba, et al.
Published: (2021) -
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
by: Beatrice Ragnoli, et al.
Published: (2023) -
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
by: Paul C Langley
Published: (2022) -
Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
by: Dorey-Stein ZL, et al.
Published: (2021) -
Symptoms and exacerbations in asthma: an apparent paradox?
by: Jaymin B. Morjaria, et al.
Published: (2019)